Dr. Zamarin on Priming Strategies in Ovarian Cancer

Dr. Zamarin on the Role of Pembrolizumab in Endometrial CancerПодробнее

Ovarian Cancer and Immunotherapy with Dr. Dmitriy ZamarinПодробнее

Dr. Zamarin on the Future Treatment Landscape of Gynecologic MalignanciesПодробнее

Strategies for Managing Long Term Recurrent Ovarian CancerПодробнее

Strategies for Managing Recurrent Ovarian CancerПодробнее

Novel Treatment Strategies in Recurrent Ovarian CancerПодробнее

Dr. Zamarin on Novel Immunotherapy Approaches in Gynecologic CancersПодробнее

Dr. Zamarin Discusses Ongoing Work With Immunotherapy in Ovarian CancerПодробнее

I/O Combination Strategies in Ovarian CancerПодробнее

Dr. Penson on Olaparib Monotherapy Vs Chemo for Ovarian CancerПодробнее

PARP inhibitor rechallenging in ovarian cancerПодробнее

Dr. Glaspy on Immunogenicity in Ovarian CancerПодробнее

Dr. Moore on the NOVA Trial for Ovarian CancerПодробнее

Dr. Konstantinopoulos on Immunotherapy in Ovarian CancerПодробнее

The Genomics of Ovarian Cancer: Overcoming Drug Resistance | Dana-Farber Cancer InstituteПодробнее

Role of Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer | Part IIПодробнее

Dr. Borst on Homologous Recombination Deficiency in Patients With Ovarian CancerПодробнее

Dr. Sabbatini on Promising Therapies in Newly Diagnosed Ovarian CancerПодробнее

Optimal Testing Methods in Ovarian CancerПодробнее